The KROMASURE™ Platform

Advanced Fluorescent Hybridization Technology

Next Generation Cytogenetics for Cell and Gene Therapy

KROMATID’s KROMASURE™ platform is the genomic
characterization fit-for-purpose solution that provides high-confidence, single-cell insights into
chromosomal integrity, structural variants, and transgene mapping.

Unlike traditional
sequencing methods, our technology directly visualizes up to thousands of single cells
at a time, offering scalable, actionable data with unprecedented clarity, helping you
confidently advance research and meet FDA regulatory requirements.

CRISPR-chrom-loss

KROMASURE™ Benefits

  • Single-cell analysis: Unlike sequencing methods, KROMASURE™ offers direct visualization of single cells, giving unparalleled insight into genome integrity, chromosomal rearrangement, and the impacts of gene editing.
  • Data Integrity: KROMASURE™ technology offers non-extrapolated, fundamental data, which increases confidence, especially for FDA submissions and regulatory reporting.
  • High-Confidence Insights: KROMASURE™ technology provides actionable insights into on- and off- target edits, structural variants, and chromosomal integrity with the ability to visualize more than 20 single cells at once, filling the gaps left by traditional analysis methods.
  • Scalability and Customization: The KROMASURE™ platform scales to meet evolving needs, offering customized, orthogonal analysis packages for various stages of research and product development.

Learn How Our Solutions Help Meet FDA Recommendations

[Genome Integrity Assessment]
Minimize Off-Target Gene Alterations Check
Orthogonal Redundant Cellular Testing for Unbiased Genome-Wide Analysis Check
Testing for Clonal Proliferation Check
Evaluate Genomic Integrity Check
Cytogenetic Testing Check
G-Banding Analysis or Other Sensitive Methods Check
Screen
Minimize Off-Target Gene Alterations Check
Orthogonal Redundant Cellular Testing for Unbiased Genome-Wide Analysis
Testing for Clonal Proliferation Check
Evaluate Genomic Integrity Check
Cytogenetic Testing Check
G-Banding Analysis or Other Sensitive Methods
InSite
Minimize Off-Target Gene Alterations
Orthogonal Redundant Cellular Testing for Unbiased Genome-Wide Analysis Check
Testing for Clonal Proliferation Check
Evaluate Genomic Integrity Check
Cytogenetic Testing Check
G-Banding Analysis or Other Sensitive Methods Check
KBand
Minimize Off-Target Gene Alterations
Orthogonal Redundant Cellular Testing for Unbiased Genome-Wide Analysis Check
Testing for Clonal Proliferation Check
Evaluate Genomic Integrity
Cytogenetic Testing Check
G-Banding Analysis or Other Sensitive Methods
PinPoint
Minimize Off-Target Gene Alterations
Orthogonal Redundant Cellular Testing for Unbiased Genome-Wide Analysis
Testing for Clonal Proliferation
Evaluate Genomic Integrity
Cytogenetic Testing
G-Banding Analysis or Other Sensitive Methods
[Genome Integrity Assessment]
Screen
Screen
InSite
InSite
KBand
KBand
PinPoint
PinPoint
Minimize Off-Target Gene Alterations Check Check
Orthogonal Redundant Cellular Testing for Unbiased Genome-Wide Analysis Check
Check Check
Testing for Clonal Proliferation Check Check Check Check
Evaluate Genomic Integrity Check Check Check
Cytogenetic Testing Check Check Check Check
G-Banding Analysis or Other Sensitive Methods Check
Check

Advanced Analytics

Paired with custom analytics and reporting purpose built for cell and gene therapy
analysis the KROMASURE™ platform data is an essential part of any cell and gene therapy
development process from Discovery to Production.

Screenshot 2025-01-29 123004

Reporting and analysis includes:

• Comprehensive chromosome structural variation across the genome or at a specific locus of interest

• The number of cells with a transgenic sequence

• Transgene insertional copy number per cell

• Low prevalence tracking of individual structural variants, as well as structural variation phenotypes

• Pair-Wise Comparison Analysis

microscope in shape
Our deep expertise has driven the development of proprietary techniques and automation, enabling us to analyze more cells with greater precision. Our detailed reporting delivers actionable insights, empowering you to make data- driven decisions with confidence.

KROMATID'S Next-Gen Cytogenetics

Here at Kromatid, we believe that visually confirming karyotype across as many cells as possible is essential.
Because when a single cell can pose risk, numbers matter.

Why does conventional cytogenetics miss the mark? It’s really all in the number of cells analyzed. FDA guidance states that visually confirming chromosome integrity with G-Banding analysis or other sensitive methods should be used. And that at very minimum, at least 20 cells should be analyzed to understand mutagenesis risk.

Why only 20 cells? Because conventional karyotyping methods, while they are the gold standard for visualizing chromosomes, are typically run on 20-50 cells. Preparation, imaging and analysis are highly manual and specialized, and analysis for mutation requires highly qualified human expertise examining each chromosome for structural abnormalities.

​

  • Analysis of 20-50 cells will detect chromosome abnormalities present in about 1 out of every 10 cells, or at 10% prevalence. Low-prevalence mutations, will be missed. ​
  • Our mission at KROMATID is to bring the power of these single cell measurements into the hundreds and thousands of cells, which we profile routinely – enabling mutations with 0.1% prevalence can be detected with confidence. 
thumbnail_Direction of Single Events graphic

Product Solutions Map

Genomic Integrity Chart_v2
painted chromosomes single

Single Cell Visualization

The KROMATID difference is our singular focus: single-cell visualization and reporting. Unlike other CRO's and labs that spread their expertise across multiple specialties, we dedicate 100% of our efforts to single-cell analysis.

This exclusive focus allows us to serve as an orthogonal confirmation and testing partner for your research and IND submissions.

KromaSure One Pager Double-Sided-1

KROMASURE™ Platform

This data sheet discusses the solutions offered through the KROMASURE platform. Our direct visualization platform can assist in providing clarity on genomic integrity, edit integrity, transgene mapping and starting material analysis. 

What products and services does your company provide?
We specialize in manufacturing high-quality industrial components and machinery parts for a variety of industries, including automotive, aerospace, and energy sectors. Our services include product design, prototyping, mass production, and after-sales support to ensure that we meet all of your manufacturing needs.
Can you customize products to meet our specific requirements?
Yes, we offer custom manufacturing solutions tailored to your unique specifications. Our experienced engineering team works closely with clients to develop custom designs, materials, and finishes to ensure the final product meets all functional and aesthetic requirements.
What is your typical lead time for production and delivery?
Our standard lead time ranges from 4 to 6 weeks, depending on the complexity and quantity of the order. We strive to meet your timelines and can often accommodate expedited production schedules upon request. Please contact us to discuss your specific needs.
What quality assurance processes do you have in place?
Quality is our top priority. We are ISO 9001:2015 certified and adhere to strict quality control protocols throughout the manufacturing process. This includes rigorous inspections, testing procedures, and compliance with industry standards to ensure that every product meets or exceeds customer expectations.
What does KROMATID do?
What are structural variants and why are they important?
Who can benefit from KROMATID's technology?
How is KROMATID different from other genomic analysis companies?
What is directional Genomic Hybridization (dGH)?
What is Pinpoint FISH and how does it work?
How does KROMATID detect structural variants?
Can KROMATID work with clinical samples (e.g., FFPE, blood, cultured cells)?
What data or results will I receive?
Do you offer custom assay development?
How can your services support cancer research or therapy development?
Can KROMATID support cell and gene therapy programs?
Do you offer preclinical or clinical support for pharmaceutical development?
Are your services applicable in rare disease research?
How do I submit a sample?
What are your pricing models?
How do I initiate a project with KROMATID?
Is my data secure and confidential?
Where can I find product documentation and protocols?
Do you provide technical support?
Can you help interpret my results?
Where is KROMATID located?
Do you offer international services?
Are you open to partnerships or collaborations?

Accelerate Your Research!

CONNECT WITH OUR EXPERTS